You are here

ramucirumab

Lilly colon cancer drug succeeds in late stage study

Yahoo/Reuters

Fri, 09/12/14 - 10:23 am

Eli Lilly Lung Cancer Drug May Succeed Where Avastin Failed

Forbes

Sun, 06/1/14 - 12:15 pm

Lilly’s Gastric Cancer Drug Wins Approval From U.S. FDA

Bloomberg

Mon, 04/21/14 - 04:58 pm

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

Yahoo/24-7 Wall St

Mon, 03/10/14 - 10:13 am

Bristol-Myers Squibb

Attack On Lung Cancer: Eli Lilly Vs. Rivals

Seeking Alpha

Mon, 02/24/14 - 09:53 am

non-small cell lung cancer

Eli Lilly's Ramucirumab for lung cancer meets Phase III survival endpoint

Yahoo/Fly on the Wall

Wed, 02/19/14 - 08:41 am

non-small cell lung cancer

Eli Lilly: 2014 Predictions

Seeking Alpha

Tue, 01/21/14 - 09:42 am

FDA Grants Lilly's Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer

Marketwatch

Thu, 10/24/13 - 10:29 am

Eli Lilly's ramucirumab for gastric cancer shows positive Phase III results

Yahoo/Fly on the Wall

Thu, 10/3/13 - 09:09 am

Lilly drug fails in breast cancer, succeeds in gastric cancer

Reuters

Thu, 09/26/13 - 08:14 am

Pipeline Vs. Expiring Patents: Eli Lilly's Future

Seeking Alpha

Thu, 06/20/13 - 11:00 am

Eli Lilly drops after cancer drug data seen as 'underwhelming'

The Fly on the Wall

Wed, 01/23/13 - 10:43 am

Lilly's ImClone Purchase Pays Off

Forbes

Mon, 10/15/12 - 11:38 am

Lilly's gastric cancer drug meets late-stage goal

Reuters

Mon, 10/15/12 - 10:41 am

Lilly releases Phase II results for monoclonal antibody ramucirumab

The Fly on the Wall

Mon, 10/1/12 - 10:25 am

monoclonal antibodies

Lilly Releases Phase II Results for Monoclonal Antibody Ramucirumab in Lung Cancer

Yahoo/PR Newswire

Sat, 09/29/12 - 12:25 pm